unknown
Stage
About
Gedea Biotech is a Swedish life science company developing pHyph, an antibiotic-free, CE-marked treatment for bacterial vaginosis that aims to restore and strengthen the vaginal microbiome. The company conducts clinical trials and is preparing commercialization of its product for pharmacies.
Explore Gedea Biotech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.